Merck Beats Q2 Estimates, Raises Revenue Outlook, Cuts Profit Guidance on Acquisition Charges
Merck beat second-quarter estimates on Tuesday and raised its 2026 revenue outlook while cutting profit guidance due to acquisition charges. The pharmaceutical company now anticipates 2026 revenue between $66.3 billion and $67.3 billion, up from $65.8 billion to $67 billion, driven by strong sales o
LucasBennett·08-04 10:39
